IGF1 and breast cancer: Consistently, in our experimental conditions addition of 10 nM OHPg reduced the cellular content of pAKT and total AKT (Fig. 4A) and its downstream target mTOR (Fig. S1) either in basal conditions or following treatment with IGF-1, a relevant factor in breast cancer growth and progression 30.